Sarah Marucci
Gastroenterology · San Antonio, TXNPI 1790163780
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $844 of the $944 with a category attached, or 89.4%. It is spread thinly across 10 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $341 and has fallen 82.8% since, to $59 in 2024. That places this record below the midpoint for gastroenterology clinicians in TX, where the typical reported total is $3,104.
Across 32 payments — averaging $29.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$224
- Johnson & Johnson$142
- Conmed Corporation$122
- AbbVie$112
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$82
- Takeda Pharmaceuticals U.S.A., Inc.$76
- plus $186 from 4 others
What the payments were for
- Food & beverage$84489%
- Education$10011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 7 | $224 |
| Johnson & Johnson | 4 | $142 |
| Conmed Corporation | 2 | $122 |
| AbbVie | 2 | $112 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Olympus America Inc. | 3 | $59 |
| Apollo Endosurgery US Inc | 1 | $55 |
| ERBE USA Inc | 1 | $45 |
| Shire North American Group Inc | 2 | $27 |
How this compares
$944 in reported general payments places this provider in the 25th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 20 | $297 |
| Omeprazole | 23 | $264 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 16 | $261 |
| Pantoprazole Sodium | 12 | $48 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in San Antonio
- Eric LawitzSan Antonio$776K
- Charles RandallSan Antonio$749K
- Sandeep PatelSan Antonio$292K
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.